Lionshead Wealth Management LLC acquired a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 714 shares of the healthcare conglomerate’s stock, valued at approximately $361,000.
Several other hedge funds have also recently bought and sold shares of UNH. NewSquare Capital LLC acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $26,000. Hurley Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $28,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. Finally, Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $30,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Price Performance
Shares of NYSE:UNH opened at $380.72 on Monday. The firm has a market cap of $345.37 billion, a PE ratio of 24.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $378.54 and a 52 week high of $630.73. The firm’s fifty day moving average is $488.01 and its 200-day moving average is $522.04.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.21%. UnitedHealth Group’s payout ratio is 35.18%.
Wall Street Analyst Weigh In
UNH has been the topic of a number of recent analyst reports. Royal Bank of Canada decreased their price objective on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. Hsbc Global Res cut shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 22nd. Robert W. Baird decreased their price objective on shares of UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 29th. KeyCorp decreased their price objective on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating on the stock in a research note on Monday, April 21st. Finally, JPMorgan Chase & Co. decreased their price objective on shares of UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Four research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $596.86.
Check Out Our Latest Stock Analysis on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- Industrial Products Stocks Investing
- Constellation Powers Up With Reinforced AI Data Center Strategy
- What Do S&P 500 Stocks Tell Investors About the Market?
- Top Analyst-Rated Healthcare Stocks to Watch Now
- How to trade using analyst ratings
- GlobalFoundries Stock Hits Bottom: Is a Rebound Coming?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.